BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11162844)

  • 1. Ubiquitin-mediated degradation of hepatitis C virus core protein is regulated by processing at its carboxyl terminus.
    Suzuki R; Tamura K; Li J; Ishii K; Matsuura Y; Miyamura T; Suzuki T
    Virology; 2001 Feb; 280(2):301-9. PubMed ID: 11162844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 Jul; 18(30):4313-25. PubMed ID: 10439039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NS2 protein generated by the parvovirus minute virus of mice is degraded by the proteasome in a manner independent of ubiquitin chain elongation or activation.
    Miller CL; Pintel DJ
    Virology; 2001 Jul; 285(2):346-55. PubMed ID: 11437668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo ubiquitination and proteasome-mediated degradation of p53(1).
    Maki CG; Huibregtse JM; Howley PM
    Cancer Res; 1996 Jun; 56(11):2649-54. PubMed ID: 8653711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid deubiquitination of nucleosomal histones in human tumor cells caused by proteasome inhibitors and stress response inducers: effects on replication, transcription, translation, and the cellular stress response.
    Mimnaugh EG; Chen HY; Davie JR; Celis JE; Neckers L
    Biochemistry; 1997 Nov; 36(47):14418-29. PubMed ID: 9398160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation.
    Dai RM; Li CC
    Nat Cell Biol; 2001 Aug; 3(8):740-4. PubMed ID: 11483959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells.
    Dantuma NP; Lindsten K; Glas R; Jellne M; Masucci MG
    Nat Biotechnol; 2000 May; 18(5):538-43. PubMed ID: 10802622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation of proto-oncoprotein c-Rel by the ubiquitin-proteasome pathway.
    Chen E; Hrdlickova R; Nehyba J; Longo DL; Bose HR; Li CC
    J Biol Chem; 1998 Dec; 273(52):35201-7. PubMed ID: 9857058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ubiquitin-proteasome pathway and proteasome inhibitors.
    Myung J; Kim KB; Crews CM
    Med Res Rev; 2001 Jul; 21(4):245-73. PubMed ID: 11410931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitylation and destruction of endogenous c-mycS by the proteasome: are myc boxes dispensable?
    Chen L; Smith L; Accavitti-Loper MA; Omura S; Bingham Smith J
    Arch Biochem Biophys; 2000 Feb; 374(2):306-12. PubMed ID: 10666312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The degradation of nascent fibrinogen chains is mediated by the ubiquitin proteasome pathway.
    Xia H; Redman C
    Biochem Biophys Res Commun; 1999 Aug; 261(3):590-7. PubMed ID: 10441471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modes of regulation of ubiquitin-mediated protein degradation.
    Kornitzer D; Ciechanover A
    J Cell Physiol; 2000 Jan; 182(1):1-11. PubMed ID: 10567911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ubiquitin-proteasome pathway: on protein death and cell life.
    Ciechanover A
    EMBO J; 1998 Dec; 17(24):7151-60. PubMed ID: 9857172
    [No Abstract]   [Full Text] [Related]  

  • 14. E6AP ubiquitin ligase mediates ubiquitylation and degradation of hepatitis C virus core protein.
    Shirakura M; Murakami K; Ichimura T; Suzuki R; Shimoji T; Fukuda K; Abe K; Sato S; Fukasawa M; Yamakawa Y; Nishijima M; Moriishi K; Matsuura Y; Wakita T; Suzuki T; Howley PM; Miyamura T; Shoji I
    J Virol; 2007 Feb; 81(3):1174-85. PubMed ID: 17108031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex.
    Hu Z; Zhang Z; Doo E; Coux O; Goldberg AL; Liang TJ
    J Virol; 1999 Sep; 73(9):7231-40. PubMed ID: 10438810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell adhesion protects c-Raf-1 against ubiquitin-dependent degradation by the proteasome.
    Manenti S; Delmas C; Darbon JM
    Biochem Biophys Res Commun; 2002 Jun; 294(5):976-80. PubMed ID: 12074572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.
    Zhang XM; Lin H; Chen C; Chen BD
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):127-33. PubMed ID: 10229667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor gamma and retinoid X receptor alpha in human keratinocytes.
    Boudjelal M; Wang Z; Voorhees JJ; Fisher GJ
    Cancer Res; 2000 Apr; 60(8):2247-52. PubMed ID: 10786691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ubiquitin-proteasome pathway is required for the function of the viral VP16 transcriptional activation domain.
    Zhu Q; Yao J; Wani G; Chen J; Wang QE; Wani AA
    FEBS Lett; 2004 Jan; 556(1-3):19-25. PubMed ID: 14706819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A viral activator of gene expression functions via the ubiquitin-proteasome pathway.
    Everett RD; Orr A; Preston CM
    EMBO J; 1998 Dec; 17(24):7161-9. PubMed ID: 9857173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.